These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 39350947)
1. Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives. Zhang Y; Bu Y; Zhao R; Han C Ther Adv Endocrinol Metab; 2024; 15():20420188241274350. PubMed ID: 39350947 [TBL] [Abstract][Full Text] [Related]
2. Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study. Lee SM; Cho GJ; Wi WY; Norwitz ER; Koo BK; Lee J; Jung YM; Kwak SH; Park CW; Jun JK; Joo SK; Oh MJ; Kim W; Park JS Hepatol Int; 2023 Apr; 17(2):367-376. PubMed ID: 36542262 [TBL] [Abstract][Full Text] [Related]
3. Metabolic Dysfunction-Associated Fatty Liver Disease and Subsequent Development of Adverse Pregnancy Outcomes. Lee SM; Jung YM; Choi ES; Kwak SH; Koo JN; Oh IH; Kim BJ; Kim SM; Kim SY; Kim GM; Joo SK; Koo BK; Shin S; Norwitz ER; Park CW; Jun JK; Kim W; Park JS Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2542-2550.e8. PubMed ID: 34798335 [TBL] [Abstract][Full Text] [Related]
4. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol. Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010 [TBL] [Abstract][Full Text] [Related]
5. Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors. Huang XJ; Yin M; Zhou BQ; Tan XY; Xia YQ; Qin CX World J Hepatol; 2023 Aug; 15(8):985-1000. PubMed ID: 37701916 [TBL] [Abstract][Full Text] [Related]
7. Lack of awareness and ethnic polarity is a major cause of metabolic associated fatty liver disease in high-risk diabetes population in South London. Ajaz S; Chamley M; Lok J; Soliman R; Khan R; Ahir K; Curtis M; Guerra-Veloz MF; Agarwal K Ther Adv Chronic Dis; 2024; 15():20406223241264539. PubMed ID: 39091507 [TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. Sarkar M; Grab J; Dodge JL; Gunderson EP; Rubin J; Irani RA; Cedars M; Terrault N J Hepatol; 2020 Sep; 73(3):516-522. PubMed ID: 32531415 [TBL] [Abstract][Full Text] [Related]
10. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484 [TBL] [Abstract][Full Text] [Related]
11. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Habibullah M; Jemmieh K; Ouda A; Haider MZ; Malki MI; Elzouki AN Front Med (Lausanne); 2024; 11():1291501. PubMed ID: 38323033 [TBL] [Abstract][Full Text] [Related]
12. Gestational Diabetes Mellitus: Unveiling Maternal Health Dynamics from Pregnancy Through Postpartum Perspectives. Mora-Ortiz M; Rivas-García L Open Res Eur; 2024; 4():164. PubMed ID: 39355538 [TBL] [Abstract][Full Text] [Related]
13. Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort. Cheng WC; Chen HF; Cheng HC; Li CY Epidemiol Health; 2024; 46():e2024024. PubMed ID: 38317531 [TBL] [Abstract][Full Text] [Related]
14. [Expert consensus on the diagnosis and treatment of obstructive sleep apnea in women]. Chinese Thoracic Society Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jun; 47(6):509-528. PubMed ID: 38858201 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of metabolic dysfunction-associated fatty liver disease and its association on adverse pregnancy outcomes in women with gestational diabetes mellitus. Chai TY; Deng D; Byth K; George J; Pasupathy D; Cheung NW Diabetes Res Clin Pract; 2022 Sep; 191():110038. PubMed ID: 35970401 [TBL] [Abstract][Full Text] [Related]
16. Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD). Roeb E Visc Med; 2021 Aug; 37(4):273-280. PubMed ID: 34540943 [TBL] [Abstract][Full Text] [Related]
17. NAFLD and MAFLD as emerging causes of HCC: A populational study. Myers S; Neyroud-Caspar I; Spahr L; Gkouvatsos K; Fournier E; Giostra E; Magini G; Frossard JL; Bascaron ME; Vernaz N; Zampaglione L; Negro F; Goossens N JHEP Rep; 2021 Apr; 3(2):100231. PubMed ID: 33748726 [TBL] [Abstract][Full Text] [Related]